Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
RHHBY
Recent Press Releases
NVS
From
Motley Fool
The OTCQX's Top 10 Experience A Shuffle In February
March 15, 2022
Tickers
ADDYY
ETHE
GBOOY
GBTC
Tags
Small Cap
JMSB
JBSAY
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
BBI
Earnings
SXTC
From
Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers
BAYRY
BAYZF
EXEL
IPSEY
Tags
Biotech
Health Care
IPSEY
From
Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
March 14, 2022
Tickers
BIIB
NVS
RHHBY
Tags
NVS
Biotech
News
From
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Tickers
ACIU
ADAP
ALDX
ALEC
Tags
IMV
ZLAB
Benzinga
From
Benzinga
OTC Markets 2021 Annual Data Review Highlights A Record 60% $ Volume Increase
March 07, 2022
Tickers
BVNNF
GBTC
OTCM
RHHBY
Tags
Market News
Benzinga
Penny Stocks
From
Benzinga
Up 1,000% in 5 Years? These Healthcare Stocks Could Pull It Off.
March 04, 2022
Tickers
AZN
HRTX
JNJ
LEGN
Tags
SGEN
Market News
HRTX
From
Motley Fool
Viatris Just Snagged a Major FDA Approval
March 03, 2022
Tickers
ABBV
NVS
REGN
RHHBY
Tags
REGN
VTRS
RHHBY
From
Motley Fool
2 Biotech Stocks That Could Make You Richer
March 02, 2022
Tickers
BMY
EXEL
ICPT
RHHBY
Tags
XBI
RHHBY
BMY
From
Motley Fool
Roche And AstraZeneca Settle Ultomiris Patent Lawsuit
February 22, 2022
Tickers
AZN
AZNCF
RHHBY
TAK
Tags
Benzinga
TAK
AZNCF
From
Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers
ANY
NVS
REGN
RHHBF
Tags
Benzinga
Market News
REGN
From
Benzinga
3 Cutting-Edge, Protein-Degrader Biotech Stocks to Watch
February 16, 2022
Tickers
ARVN
BIIB
CCCC
GOOG
Tags
GOOG
RHHBY
SNY
From
Motley Fool
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
February 14, 2022
Tickers
BNPQY
CYDY
EEENF
ETHE
Tags
Markets
CYDY
BNPQY
From
Benzinga
Why Are Seagen Shares Sinking Today?
February 10, 2022
Tickers
GSK
MRK
RHHBY
SGEN
Tags
Biotech
Health Care
Market News
From
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Tickers
ABBV
ACLX
ALNY
AMGN
Tags
AMGN
FRLN
AVRO
From
Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
February 05, 2022
Tickers
ARKG
BNTX
MRK
PFE
Tags
ARKG
RHHBY
Cathie Wood
From
Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Tickers
ABMD
ARWR
BIIB
BMY
Tags
PRDS
BIIB
GRTX
From
Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
RHHBY
General
Briefs
From
Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers
NVS
RHHBF
RHHBY
RHHVF
Tags
Health Care
Large Cap
Biotech
From
Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers
BIIB
RHHBF
RHHBY
RHHVF
Tags
Market News
Benzinga
Non Hodgkin Lymphoma
From
Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
January 31, 2022
Tickers
ABBV
ABMD
AMLX
ARWR
Tags
TWST
JNJ
IRMD
From
Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
January 31, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
Health Care
Biotech
Age/Related Macular Degeneration
From
Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
January 25, 2022
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
Benzinga
RHHBF
From
Benzinga
These OTC Securities Had the Most Trading Activity in December
January 25, 2022
Tickers
ADDYY
AKZOY
BNPQY
CYDVF
Tags
Partner Content
DANOY
NGLOY
From
Benzinga
3 Clinical Trials to Watch in the First Half of 2022
January 22, 2022
Tickers
ABBV
ARNA
BIIB
JPM
Tags
PFE
VRTX
Market News
From
Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
January 16, 2022
Tickers
AZN
BGNE
JPM
LPTX
Tags
AZN
PIRS
RHHBY
From
Motley Fool
Where Will Biogen Be in 5 Years?
January 15, 2022
Tickers
BIIB
NVS
RHHBY
SAGE
Tags
NVS
Market News
RHHBY
From
Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
January 12, 2022
Tickers
BIIB
LLY
RHHBY
Tags
LLY
RHHBY
BIIB
From
MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
Health Care
BIIB
Biotech
From
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.